Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2019

01-12-2019 | Type 2 Diabetes | Research article

Lean body mass and risk of type 2 diabetes - a Danish cohort study

Authors: Christine Friis Baker, Kim Overvad, Christina Catherine Dahm

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2019

Login to get access

Abstract

Purpose

Excess body fat is a commonly known risk factor for type 2 diabetes. However, whether lean body mass, or fat free mass, could have a protective effect against type 2 diabetes, remains unclear. The aim of this study was to explore the association between lean body mass, fat mass and type 2 diabetes.

Methods

This study used data from the Danish Diet, Cancer and Health cohort of 37,053 men and women, aged 50–64 years at baseline (1993–1997). The exposure was measurements of body composition using bioelectrical impedance analysis. Incident diabetes during follow-up was determined through linkage to the Danish National Diabetes Register. Cox proportional hazards regression analysis was used to estimate HR and 95%CI for the association between lean body mass and incident type 2 diabetes, with and without adjustment for fat mass. A sensitivity analysis was performed, excluding cases of incident type 2 diabetes within the first 2 years of follow-up.

Results

When adjusted for fat mass, the main analysis showed non-linear inverse association between lean body mass and risk of diabetes for men, but not for women. However, the sensitivity analysis found no association for either men or women.

Conclusions

Lean body mass was not associated with incident type 2 diabetes when excluding cases that may have been subclinical at baseline. The results imply that public health should focus on reduction of fat mass for diabetes prevention.
Literature
3.
go back to reference Weisman A, Fazli GS, Johns A, Booth GL. Evolving trends in the epidemiology, risk factors, and prevention of Type 2 Diabetes: a review. Can J Cardiol. 2018;34(5):552–64.PubMedCrossRef Weisman A, Fazli GS, Johns A, Booth GL. Evolving trends in the epidemiology, risk factors, and prevention of Type 2 Diabetes: a review. Can J Cardiol. 2018;34(5):552–64.PubMedCrossRef
4.
go back to reference Son JW, Lee SS, Kim SR, Yoo SJ, Cha BY, Son HY, et al. Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia. 2017;60(5):865–72.PubMedCrossRef Son JW, Lee SS, Kim SR, Yoo SJ, Cha BY, Son HY, et al. Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES. Diabetologia. 2017;60(5):865–72.PubMedCrossRef
7.
go back to reference Larsen BA, Wassel CL, Kritchevsky SB, Strotmeyer ES, Criqui MH, Kanaya AM, et al. Association of Muscle Mass, area, and strength with incident diabetes in older adults: the health ABC study. J Clin Endocrinol Metab. 2016;101(4):1847–55.PubMedPubMedCentralCrossRef Larsen BA, Wassel CL, Kritchevsky SB, Strotmeyer ES, Criqui MH, Kanaya AM, et al. Association of Muscle Mass, area, and strength with incident diabetes in older adults: the health ABC study. J Clin Endocrinol Metab. 2016;101(4):1847–55.PubMedPubMedCentralCrossRef
8.
go back to reference Li JJ, Wittert GA, Vincent A, Atlantis E, Shi Z, Appleton SL, et al. Muscle grip strength predicts incident type 2 diabetes: population-based cohort study. Metabolism. 2016;65(6):883–92.PubMedCrossRef Li JJ, Wittert GA, Vincent A, Atlantis E, Shi Z, Appleton SL, et al. Muscle grip strength predicts incident type 2 diabetes: population-based cohort study. Metabolism. 2016;65(6):883–92.PubMedCrossRef
9.
go back to reference Garg SK, Maurer H, Reed K, Selagamsetty R. Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab. 2013;16(2):97–110.PubMedCrossRef Garg SK, Maurer H, Reed K, Selagamsetty R. Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab. 2013;16(2):97–110.PubMedCrossRef
10.
go back to reference Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. Nerurkar PV, editor. PLoS ONE. 2018;13(3):e0194127.PubMedPubMedCentralCrossRef Bellou V, Belbasis L, Tzoulaki I, Evangelou E. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. Nerurkar PV, editor. PLoS ONE. 2018;13(3):e0194127.PubMedPubMedCentralCrossRef
11.
go back to reference Kjøbsted R, Hingst JR, Fentz J, Foretz M, Sanz M-N, Pehmøller C, et al. AMPK in skeletal muscle function and metabolism. FASEB J. 2018 Apr;32(4):1741–77.PubMedPubMedCentralCrossRef Kjøbsted R, Hingst JR, Fentz J, Foretz M, Sanz M-N, Pehmøller C, et al. AMPK in skeletal muscle function and metabolism. FASEB J. 2018 Apr;32(4):1741–77.PubMedPubMedCentralCrossRef
12.
go back to reference Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3(1):1–58.PubMedPubMedCentral Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3(1):1–58.PubMedPubMedCentral
13.
go back to reference Tjønneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, et al. Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health. 2007;35(4):432–41.PubMedCrossRef Tjønneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, et al. Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health. 2007;35(4):432–41.PubMedCrossRef
14.
15.
go back to reference Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701.PubMedCrossRef Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701.PubMedCrossRef
16.
go back to reference Stegger JG, Schmidt EB, Obel T, Berentzen TL, Tjønneland A, Sørensen TIA, et al. Body composition and body fat distribution in relation to later risk of acute myocardial infarction: a Danish follow-up study. Int J Obes. 2011;35(11):1433–41.CrossRef Stegger JG, Schmidt EB, Obel T, Berentzen TL, Tjønneland A, Sørensen TIA, et al. Body composition and body fat distribution in relation to later risk of acute myocardial infarction: a Danish follow-up study. Int J Obes. 2011;35(11):1433–41.CrossRef
17.
go back to reference Heitmann BL. Prediction of body water and fat in adult Danes from measurement of electrical impedance. A validation study. Int J Obes. 1990;14(9):789–802.PubMed Heitmann BL. Prediction of body water and fat in adult Danes from measurement of electrical impedance. A validation study. Int J Obes. 1990;14(9):789–802.PubMed
18.
go back to reference Bigaard J, Spanggaard I, Thomsen BL, Overvad K, Tjønneland A. Self-reported and technician-measured waist circumferences differ in middle-aged men and women. J Nutr. 2005;135(9):2263–70.PubMedCrossRef Bigaard J, Spanggaard I, Thomsen BL, Overvad K, Tjønneland A. Self-reported and technician-measured waist circumferences differ in middle-aged men and women. J Nutr. 2005;135(9):2263–70.PubMedCrossRef
19.
go back to reference Carstensen B, Kristensen JK, Marcussen MM, Borch-Johnsen K. The National Diabetes Register. Scand J Public Health. 2011;39(7_suppl):58–61.PubMedCrossRef Carstensen B, Kristensen JK, Marcussen MM, Borch-Johnsen K. The National Diabetes Register. Scand J Public Health. 2011;39(7_suppl):58–61.PubMedCrossRef
20.
go back to reference Malavolti M, Mussi C, Poli M, Fantuzzi AL, Salvioli G, Battistini N, et al. Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years. Ann Hum Biol. 2003;30(4):380–91.PubMedCrossRef Malavolti M, Mussi C, Poli M, Fantuzzi AL, Salvioli G, Battistini N, et al. Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years. Ann Hum Biol. 2003;30(4):380–91.PubMedCrossRef
22.
go back to reference Ling CHY, de Craen AJM, Slagboom PE, Gunn DA, Stokkel MPM, Westendorp RGJ, et al. Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population. Clin Nutr. 2011;30(5):610–5.PubMedCrossRef Ling CHY, de Craen AJM, Slagboom PE, Gunn DA, Stokkel MPM, Westendorp RGJ, et al. Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in middle-aged adult population. Clin Nutr. 2011;30(5):610–5.PubMedCrossRef
23.
go back to reference Moon JR, Stout JR, Smith-Ryan AE, Kendall KL, Fukuda DH, Cramer JT, et al. Tracking fat-free mass changes in elderly men and women using single-frequency bioimpedance and dual-energy X-ray absorptiometry: a four-compartment model comparison. Eur J Clin Nutr. 2013;67(S1):S40–6.PubMedCrossRef Moon JR, Stout JR, Smith-Ryan AE, Kendall KL, Fukuda DH, Cramer JT, et al. Tracking fat-free mass changes in elderly men and women using single-frequency bioimpedance and dual-energy X-ray absorptiometry: a four-compartment model comparison. Eur J Clin Nutr. 2013;67(S1):S40–6.PubMedCrossRef
24.
go back to reference Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2(10):819–29.PubMedPubMedCentralCrossRef Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2(10):819–29.PubMedPubMedCentralCrossRef
25.
go back to reference Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreau R, de Rekeneire N, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009;32(11):1993–7.PubMedPubMedCentralCrossRef Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreau R, de Rekeneire N, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009;32(11):1993–7.PubMedPubMedCentralCrossRef
26.
go back to reference Misra A, Khurana L. Obesity-related non-communicable diseases: south Asians vs white Caucasians. Int J Obes 2005. 2011;35(2):167–87.CrossRef Misra A, Khurana L. Obesity-related non-communicable diseases: south Asians vs white Caucasians. Int J Obes 2005. 2011;35(2):167–87.CrossRef
27.
go back to reference Han SJ, Kim HJ, Kim DJ, Lee KW, Cho NH. Incidence and predictors of type 2 diabetes among Koreans: a 12-year follow up of the Korean genome and epidemiology study. Diabetes Res Clin Pract. 2017;123:173–80.PubMedCrossRef Han SJ, Kim HJ, Kim DJ, Lee KW, Cho NH. Incidence and predictors of type 2 diabetes among Koreans: a 12-year follow up of the Korean genome and epidemiology study. Diabetes Res Clin Pract. 2017;123:173–80.PubMedCrossRef
Metadata
Title
Lean body mass and risk of type 2 diabetes - a Danish cohort study
Authors
Christine Friis Baker
Kim Overvad
Christina Catherine Dahm
Publication date
01-12-2019
Publisher
Springer International Publishing
Keyword
Type 2 Diabetes
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2019
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-019-00438-7

Other articles of this Issue 2/2019

Journal of Diabetes & Metabolic Disorders 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.